Fundraising Fox
Levee Medical
Durham, US · Founded 2018 · Delaware corporation
Find your way into Levee Medical
Sign up to see every warm intro you have to Levee Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Levee Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Levee Medical develops the Voro Urologic Scaffold, an absorbable medical device designed to reduce urinary incontinence in men following radical prostatectomy for prostate cancer. The device is in the research and development phase and not yet approved for sale.
Founders & leadership
Board
PM
Peter MulrooneyBoard director
GM
Gary McCordBoard director
Reported raises · per SEC filings
Form D private placements$28.3M disclosed across 5 rounds · 2021–2025
▶$12.5MraisedMay 2026 · 130 investors · Other Health CareRule 506(b)
▶$12.5MraisedMay 2026 · 130 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Peter MulrooneyDirector
- Bruce ChoiExecutive Officer, Director
- Gary McCordDirector
- Mike HensonDirector
- Adam IrvingExecutive Officer, Director
- Offering amount
- $12.5M
- Amount sold
- $12.5M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.5MraisedAug 2024 · 70 investors · Other Health CareRule 506(b)
▶$6.5MraisedAug 2024 · 70 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Bruce ChoiExecutive Officer, Director
- Adam IrvingExecutive Officer, Director
- Peter MulrooneyDirector
- Gary McCordDirector
- Offering amount
- $10M
- Amount sold
- $6.5M
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.4MraisedJul 2023 · 34 investors · Other Health CareRule 506(b)
▶$3.4MraisedJul 2023 · 34 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Adam IrvingExecutive Officer, Director
- Peter MulrooneyDirector
- Bruce ChoiExecutive Officer, Director
- Gary McCordDirector
- Offering amount
- $4.3M
- Amount sold
- $3.4M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.3MraisedJul 2022 · 54 investors · Other Health CareRule 506(b)
▶$3.3MraisedJul 2022 · 54 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Bruce ChoiExecutive Officer, Director
- Gary McCordDirector
- Peter MulrooneyDirector
- Adam IrvingExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $3.3M
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$2.6MraisedJan 2022 · 49 investors · Other Health CareRule 506(b)
▶$2.6MraisedJan 2022 · 49 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Bruce ChoiExecutive Officer, Director
- Adam IrvingExecutive Officer
- Offering amount
- $2.6M
- Amount sold
- $2.6M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
LaborieLaborie develops medical devices and solutions for women's health, including technologies to manage complications like postpartum hemorrhage.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
CqmedicalCQ Medical develops patient positioning and immobilization products used in radiation therapy, including devices for brachytherapy, SBRT, SRS, and proton treatments. Its offerings serve oncology and radiotherapy clinicians treating cancer and conditions such as osteoarthritis.
Companies working in the same space as Levee Medical.
In the news
Frequently asked questions
- What does Levee Medical do?
- Levee Medical develops the Voro Urologic Scaffold, an absorbable medical device designed to reduce urinary incontinence in men following radical prostatectomy for prostate cancer. The device is in the research and development phase and not yet approved for sale.
- How much funding has Levee Medical raised?
- Levee Medical has disclosed $28.3M raised across 5 rounds.
- Where is Levee Medical headquartered?
- Levee Medical is headquartered in Durham, US.